✦ LIBER ✦

O-20-4 - The M1 muscarinic agonist xanomeline improves both cognitive and behavioral deficits in Alzheimer's disease

✍ Scribed by N. Bodick; W. Offen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

557 The MI-selective muscarinic agonist

✍ N. Bodick; W. Offen 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 256 KB

182 The effects of xanomeline, an M1-sel

✍ N. Bodick; W. Offen; K. Rasmussen; S. Paul 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 122 KB

41-5 - Transdermal delivery of xanomelin

✍ N.C. Bodick; R. Lucas; J.H. Satterwhite; W.W. Offen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 429 KB

SAT-5-3 Xanomeline in mild and moderate

✍ Neil C. Bodick; Walter Offen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 278 KB

S-16-4 Xanomeline: The first study of th

✍ Neil C. Bodick; Walter Offen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Cognitive and behavioral improvements in

✍ Abraham Fisher; Emeline Keller 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 185 KB